ImmuneID Funding: $113M Raised, Series A (2022)

ImmuneID funding overview

ImmuneID is based in Cambridge, Massachusetts. ImmuneID has raised $113M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in June 2022. The round record for ImmuneID runs through 2022; nothing later has been disclosed. Investors on record include Alta Partners, Arch Venture Partners, Longwood Fund, Alexandria Venture Investments, Domain, Taiho. 6 distinct backers are named across the disclosed rounds.

ImmuneID at a glance

Total raised: $113M
Latest round: Series A
Latest round date: June 2022
Headquarters: Cambridge, Massachusetts
Notable investors: Alta Partners, Arch Venture Partners, Longwood Fund, Alexandria Venture Investments, Domain, Taiho

Frequently asked about ImmuneID funding

How much has ImmuneID raised?: ImmuneID has raised $113M in total disclosed funding across the rounds on record.
Who has invested in ImmuneID?: Alta Partners, Arch Venture Partners, Longwood Fund, Alexandria Venture Investments, Domain, Taiho are named among the investors backing ImmuneID.
What was the latest ImmuneID funding round?: The most recent disclosed round is a Series A, announced in June 2022.
Where is ImmuneID based?: ImmuneID is based in Cambridge, Massachusetts.
When did ImmuneID last raise?: The last disclosed ImmuneID round closed in June 2022 at Series A.

Round data for ImmuneID is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Cambridge and backer lists below.

ImmuneID Funding: $113M Raised, Series A (2022)

ImmuneID funding overview

ImmuneID at a glance

Frequently asked about ImmuneID funding

Companies related to ImmuneID (36)

Browse related funding lists (9)